TY - JOUR
T1 - HLA-B*51 allelic and carrier frequency in Kazakhstan
T2 - insights into Behçet’s disease prevalence in Central Asia
AU - Poddighe, Dimitri
AU - Turganbekova, Aida
AU - Mukusheva, Zaure
AU - Abdirakhmanova, Altynay
AU - Assylbekova, Maikesh
AU - Abdrakhmanova, Saniya
PY - 2020
Y1 - 2020
N2 - Behçet’s disease (BD) is a systemic vasculitis whose prevalence varies according to the ethnicity. HLA-B*51 is a well-known genetic factor predisposing to BD: populations with higher HLA-B*51 allelic frequencies are also those with a greater disease prevalence, as occurs in the Silk Road countries. However, the BD prevalence is unknown in many countries, including Kazakhstan and, in general, Central Asia, despite the location on or near the Silk Road. Due to the lack of clinical studies from this area, we analyzed the bone marrow donors registry in Kazakhstan, in order to assess the HLA-B*51 allelic and carrier frequencies, which resulted to be 8.14 and 15.28%, respectively. Through a comparison with the same parameters in other countries (by performing a data search in the medical literature and in the Allele Frequency Net Database), we might speculate a BD prevalence in Kazakhstan of 10–15/100.000 at least. This result should prompt a greater clinical consideration of this disease in Central Asia, as well as the publication of clinical data from this geographic area.
AB - Behçet’s disease (BD) is a systemic vasculitis whose prevalence varies according to the ethnicity. HLA-B*51 is a well-known genetic factor predisposing to BD: populations with higher HLA-B*51 allelic frequencies are also those with a greater disease prevalence, as occurs in the Silk Road countries. However, the BD prevalence is unknown in many countries, including Kazakhstan and, in general, Central Asia, despite the location on or near the Silk Road. Due to the lack of clinical studies from this area, we analyzed the bone marrow donors registry in Kazakhstan, in order to assess the HLA-B*51 allelic and carrier frequencies, which resulted to be 8.14 and 15.28%, respectively. Through a comparison with the same parameters in other countries (by performing a data search in the medical literature and in the Allele Frequency Net Database), we might speculate a BD prevalence in Kazakhstan of 10–15/100.000 at least. This result should prompt a greater clinical consideration of this disease in Central Asia, as well as the publication of clinical data from this geographic area.
KW - Allelic frequency
KW - Behçet’s disease
KW - Central Asia
KW - HLA-B57
KW - Kazakhstan
KW - Prevalence
UR - http://www.scopus.com/inward/record.url?scp=85085903439&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085903439&partnerID=8YFLogxK
U2 - 10.1007/s11739-020-02369-1
DO - 10.1007/s11739-020-02369-1
M3 - Article
AN - SCOPUS:85085903439
JO - Internal and Emergency Medicine
JF - Internal and Emergency Medicine
SN - 1828-0447
ER -